MediWound offers hope for chronic wound treatment - studyIn a phase II study, EscharEx demonstrated safe and effective debridement of diabetic foot ulcers and venous leg ulcers. MediWound's CEO Sharon Malka(photo credit: YOSSI ZELIGER)